Table 4.
Multivariate analysis of the social and clinical characteristics of patients with schizophrenia who use atypical antipsychotics.
| Characteristic | HR | 95%CI | p value | |
|---|---|---|---|---|
| Sex | Female | 1 | ||
| Male | 1.30 | 1.27–1.32 | <0.001 | |
| Age group | 18 - 40 years | 1 | ||
| 41 - 59 years | 2.63 | 2.54–2.72 | <0.001 | |
| ≥ 60 years | 17.05 | 16.52–17.60 | <0.001 | |
| Region of residence | Other regions | 1 | ||
| Southeast | 1.20 | 1.17–1.23 | <0.001 | |
| Atypical antipsychotic | Clozapine | 1 | <0.001 | |
| Non-clozapine | 1.21 | 1.14–1.29 | ||
| Hospitalized for cardiovascular disease | No | 1 | ||
| Yes | 1.44 | 1.40–1.49 | <0.001 | |
| Hospitalized for pneumonia | No | 1 | ||
| Yes | 2.17 | 2.11–2.23 | <0.001 | |
| Hospitalized for lung cancer | No | 1 | ||
| Yes | 1.82 | 1.58–2.08 | <0.001 | |
| Hospitalized for any neoplasia | No | 1 | ||
| Yes | 1.29 | 1.19–1.40 | <0.001 |
SUS, National Health System; HR, Hazard Ratio; 95%CI, 95% confidence interval.